by Raynovich Rod | Nov 2, 2026 | Biopharmaceuticals, Healthcare stocks
Update-1…11/4/26 240P EST…DEMs Win should support further healthcare gains: XLV up 2.83% at $189 ; latest new pick GE Healthcare(GEHC) continues to show gains up 34% MTD at $86. IBB up 1.78% to $219 at a double top. MEDtech on the move with ABT up 5.8%,...
by Raynovich Rod | Oct 29, 2026 | 2024-25 Life Science Portfolios, Biopharmaceuticals
Trading Model for SMID Biotech Stocks- Outperfomed the Market in 2026 Our bullish call for Biotech Stocks was made in January 2026 after the JPMorgan Healthcare Conference. Our Trading Model selected a Portfolio of SMID Biotech stocks, Mutual Funds and ETFs to buy....
by Raynovich Rod | Oct 19, 2026 | Biopharmaceuticals, Healthcare stocks
10/27/26…….Update-5..Momentum continues as AI rolls on from Anthropic buzz with chip stock strength. SMH up over 3% and QQQs up over 1%. But biotechs get pulled along with tape and seasonality favors SMID biotechs thru early January. IBB up 1.63% in...
by Raynovich Rod | Oct 12, 2026 | Biopharmaceuticals
Update-3 .10/20/26..3:45 p EDT SMID biotch rally with a green screen!…XLV momentum beats techs right now. RISK is on for healthcare and biotech. Update-2….1016/26- ….Tech wreck continues with focus on AI infrastructure funding and capital. Need to...
by Raynovich Rod | Sep 28, 2026 | Biopharmaceuticals, Healthcare stocks
Update-5…10/9/26..3:17p EDT ALERT: Out of Nowhere comes a GREEN SCREEN in biotech!! IBB and XBI up 3%. Update-4 10/726 …Massive selling in ARKG yesterday took many genomics stocks down , now trading at about $50, down 7.58% over 5 days. Still In...
by Raynovich Rod | Sep 23, 2026 | Biopharmaceuticals, Macro
Update-1 Biotech and healthcare stocks look pretty good right now with many large caps still near their highs even Biogen (BIIB) at $228. The IBB at $209 has recovered from the mid-month sell-off. The XBI has lost momentum down 8% for the month, but should rally into...
by Raynovich Rod | Sep 15, 2026 | Biopharmaceuticals, Healthcare stocks
Update-1 SMID biotech movers today-Morgan Stanley Healthcare presentation- from our Focus Trading List: Many of these stocks are in the Cathy Wood managed ETF (ARKG). A green screen day in GENOMICS. We are long all of them. Adaptive Biotechnologies (ADPT) up 7.67% to...
by Raynovich Rod | Sep 9, 2026 | Biopharmaceuticals, Energy
Dow (DIA) is Down 2.3% month to date The XLV was down 2.52% to $167 reflecting the weighting of large cap biophrarma drugs in the ETF, the IBB was down 2.17% to the $207 level. The XLK was up only 0.32% but other tech sectors did better but volatile; SMH up...
by Raynovich Rod | Sep 1, 2026 | Biopharmaceuticals, Healthcare stocks
Update-3 -9/11/26… A lot of changes this week especially healthcare with the XLV down about 4.5% wtd.The S&P 500 held up well down a little over 1% and the NASDAQ -100 (QQQ), down only 0.38% wtd. The XLK was up 0.93% wtd despite all the headline news against...
by Raynovich Rod | Aug 24, 2026 | Biopharmaceuticals, Healthcare stocks
Update-3,,,,8/29/26….Despite some big news this week, healthcare and biotech stocks reversed and sold off from the 2026 top. Revolution Medicine (RVMD) sold off 6% from its daily trading high on the news that the FDA approved its targeted therapy for pancreatic...
